Stock listing

NASDAQ:SWTX SpringWorks Therapeutics Inc Stock

Follow SpringWorks Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SWTX

$46.99 USD

Close on Jun 30, 2025 · No longer trades

Sep 13, 2019 to last close +107.6% · weekly closes, Sep 13, 2019 – Jun 30, 2025
Lowest – highest close
$17.74 – $93.59 USDSince Sep 13, 2019 · lowest Nov 14, 2019 · highest Feb 24, 2021

Delisted NASDAQ:SWTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SWTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

SpringWorks Therapeutics Inc on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Nov 12, 2024
Decks
5 decks · latest Nov 28, 2023

Events

CallWhenStatus
SpringWorks Therapeutics (SWTX) Q3 2024 Earnings CallTue, Nov 12, 2024 · 8:30 AM ETReplay
SpringWorks Therapeutics (SWTX) Q2 2024 Earnings CallWed, Aug 07, 2024 · 8:30 AM ETReplay
SpringWorks Therapeutics (SWTX) Q1 2024 Earnings CallThu, May 02, 2024 · 8:30 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Corporate Update (November 2023)Corporate update24 slidesNov 28, 2023
Corporate Update (November 2023)Corporate update23 slidesNov 17, 2023
Technical Presentation (September 2022)Technical17 slidesSep 12, 2022
Investor Day (June 2022)Investor day87 slidesJun 10, 2022
Investor Presentation (December 2019)Investor deck35 slidesDec 9, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carl Gordon
Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past)
Director · Sep 12, 2019 – Sep 12, 2019 · Past
Daniel Lynch
Other companies: TCGX Acquisition Corp. (Chairman of the TriGemX Bio Board of Directors · Since Nov 9, 2026); Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 24, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past)
Director · Since at least Sep 12, 2019
Alan Fuhrman
Other companies: Tyra Biosciences, Inc. (Chief Financial Officer · Since at least Jan 1, 2023); Checkmate Pharmaceuticals Inc (Director · Aug 6, 2020 – May 31, 2022 · Past); Esperion Therapeutics, Inc. (Director · Mar 16, 2020 – May 23, 2024 · Past); Synlogic Inc (Chief Financial Officer · Sep 30, 2015 – Mar 11, 2016 · Past); Loxo Oncology Inc (Director · Jan 12, 2015 – Feb 15, 2019 · Past); Ambit Biosciences Corp (Chief Financial Officer · May 15, 2013 – Nov 10, 2014 · Past); Achieve Life Sciences, Inc. (Senior Vice President & CFO · Dec 16, 2005 – Mar 18, 2008 · Past)
Director · Since at least Sep 12, 2019
Deval Patrick
Other companies: Toast, Inc. (Board Member · Since at least Sep 21, 2021); Twilio Inc. (Director · Since at least Jan 13, 2021); Cerevel Therapeutics Holdings Inc (Director · Jan 20, 2021 – Aug 1, 2024 · Past); Environmental Impact Acquisition Corp. (Director · Jan 13, 2021 – Jan 13, 2021 · Past); American Well Corporation (Director · Sep 16, 2020 – Jun 22, 2023 · Past); Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Oct 5, 2022 · Past)
Director · Sep 12, 2019 – Sep 12, 2019 · Past
Martin Mackay
Other companies: Kailera Therapeutics, Inc. (Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Alexion Pharmaceuticals Inc (EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past)
Director · Since at least Jul 29, 2024
Freda Lewis-Hall
Other companies: CDT Equity Inc. (Director · Since at least Sep 22, 2023); Pyxis Oncology, Inc. (Director · Since at least Oct 7, 2021); EXACT Sciences Corporation (Director · Apr 22, 2020 – Jun 8, 2023 · Past); 1Life Healthcare Inc (Director · Jan 30, 2020 – Feb 22, 2023 · Past); Pfizer, Inc. (Executive Vice President · Feb 22, 2018 – Feb 27, 2019 · Past)
Director · Since at least Mar 29, 2019
Stephen P Squinto
Other companies: Chemomab Therapeutics Ltd. (Director · Mar 16, 2021 – Apr 19, 2021 · Past); Compass Therapeutics, Inc. (Director · Jun 17, 2020 – Feb 18, 2022 · Past); Passage Bio, Inc. (Head of Research and Dev, Director · Feb 27, 2020 – Feb 27, 2020 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Oct 8, 2017 · Past); Alexion Pharmaceuticals Inc (EVP, Chief Global Ops. Officer · Jan 9, 2006 – Oct 27, 2014 · Past)
Director · Mar 29, 2019 – May 19, 2022 · Past
Jeffrey Lawrence Schwartz
Other companies: Kestra Medical Technologies, Ltd. (Director · Since at least Mar 6, 2025); Rapid Micro Biosystems, Inc. (Director · Jul 14, 2021 – May 23, 2024 · Past); BCLS Acquisition Corp (Chief Executive Officer, Director · Oct 21, 2020 – Oct 26, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Dec 18, 2017 – Dec 18, 2017 · Past)
Director · Mar 29, 2019 – May 24, 2023 · Past
Julie Hambleton
Other companies: Erasca, Inc. (Board Director · Since at least Jul 15, 2021); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); IDEAYA Biosciences, Inc. (SVP, Chief Medical Officer · May 22, 2019 – Feb 21, 2020 · Past); Five Prime Therapeutics Inc (EVP & Chief Medical Officer · Sep 17, 2013 – Nov 11, 2015 · Past)
Director · Since at least May 20, 2020
Carlos Albán
Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); AbbVie Inc. (Vice Chairman · Dec 7, 2012 – Nov 16, 2020 · Past); Abbott Laboratories (Senior Vice President · Oct 15, 2009 – Dec 1, 2012 · Past)
Director · Since at least Jul 14, 2022
All 23 people
PersonSeat
Michael F Burgess
Other companies: Turnstone Biologics Corp. (Interim Chief Medical Officer, Director · Jul 20, 2023 – Oct 16, 2023 · Past); Synlogic Inc (Director · Feb 3, 2020 – Jun 22, 2023 · Past)
Head of Research & Development · May 10, 2021 – Jul 18, 2022 · Past
Michael Nofi
Other companies: Edgewise Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 10, 2025); Perfumania Holdings Inc (CFO · Apr 28, 2017 – Apr 28, 2017 · Past)
Chief Accounting Officer · Since at least Nov 11, 2019
Perier I Francis Jr
Other companies: Clinical Data Inc (Vice President · Apr 13, 2011 – Apr 13, 2011 · Past); Forest Laboratories Inc (EVP - Chief Financial Officer · Dec 8, 2006 – Jul 1, 2014 · Past)
Chief Financial Officer · Since at least Sep 12, 2019
Saqib Islam
Other companies: Passage Bio, Inc. (Director · Since at least May 27, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020)
Chief Executive Officer, Director · Since at least Jan 7, 2021
Badreddin Edris
Other companies: Edgewise Therapeutics, Inc. (Director and Co-Founder · Since at least Mar 25, 2021)
Chief Operating Officer · Since at least Sep 12, 2019
Bhavesh Ashar
Other companies: Tyra Biosciences, Inc. (Chief Operating Officer · Since at least Dec 1, 2025)
Chief Commercial Officer · Since at least Mar 22, 2021
Herschel S Weinstein
Other companies: Forest Laboratories Inc (SVP General Counsel · Jan 30, 2006 – Oct 23, 2013 · Past)
General Counsel & Secretary · Since at least Jan 27, 2020
Michael Greco
Other companies: Veradermics, Incorporated (General Counsel · Since at least Feb 3, 2026)
General Counsel & Secretary · Sep 12, 2019 – Sep 12, 2019 · Past
Daniel PichlChief People Officer · Since at least Aug 3, 2020
James CassidyChief Medical Officer · Since at least Oct 6, 2022
Jens RenstrupChief Medical Officer · Sep 12, 2019 – Jan 7, 2021 · Past
L Mary SmithChief Development Officer · Sep 12, 2019 – Jan 4, 2024 · Past
Tai-An LinChief Scientific Officer · Since at least Sep 11, 2023

Open People

Log in to ask 6ix AI your own questions about SpringWorks Therapeutics Inc.